Suppr超能文献

一名8个月大女孩患伴有11;19易位和X三体的双克隆白血病(O-ALL/AMoL)

[Biclonal leukemia O-ALL/AMoL) with 11;19 translocation and trisomy X in an 8-month-old girl].

作者信息

Fengler R, Baumgarten E, Buchmann S, Creutzig U, Harbott J, Ludwig R, Henze G

出版信息

Klin Padiatr. 1986 May-Jun;198(3):178-82. doi: 10.1055/s-2008-1026874.

Abstract

Biclonal leukemia was diagnosed in an 8 months old girl, combining lymphoblastic (FAB L1) and monoblastic (FAB M 5) phenotypes which were classified as O-ALL and AMol by immunological examination of surface-antigens. Chemotherapy for one cell type resulted in predominance or relapse of the other one. Chromosomal abnormalities diagnosed in the lymphoblastic clone consisted of translocation t(11;19)(q23;p13) and triple X. The breakpoint 11q23 neighbouring one well known oncogene (ets) is not strictly associated with special leukemic phenotypes. But it is often found in infants and usually correlated with a poor prognosis. The data of 18 patients with hybrid leukemias registered in the BFM studies strongly support the fatal course of the disease. 12 months after diagnosis approximately 1 out of 10 children is expected to survive disease-free.

摘要

一名8个月大的女孩被诊断为双克隆白血病,其结合了淋巴细胞母细胞性(FAB L1)和单核母细胞性(FAB M5)表型,通过表面抗原免疫检查分别归类为O-ALL和急性单核细胞白血病。针对一种细胞类型的化疗会导致另一种细胞类型占优势或复发。在淋巴细胞母细胞克隆中诊断出的染色体异常包括易位t(11;19)(q23;p13)和三倍体X。与一个著名癌基因(ets)相邻的11q23断点与特殊白血病表型并无严格关联。但它常在婴儿中发现,且通常与预后不良相关。在BFM研究中登记的18例混合性白血病患者的数据有力地支持了该疾病的致命病程。诊断后12个月,预计每10名儿童中约有1名能无病存活。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验